Kenya Pharmaceuticals and Healthcare Report Q3 2009

Table of Contents

Executive Summary 5
SWOT Analysis6
Kenya Pharmaceuticals And Healthcare Industry SWOT 6
Kenya Political SWOT 7
Kenya Economic SWOT 7
Kenya Business Environment SWOT 8
Pharmaceutical Business Environment Ratings 9
Table: Middle East And North Africa Pharmaceutical Business Environment Ratings 9
Limits To Potential Returns 10
Risks To Realisation Of Returns 10
Kenya - Market Summary 12
Regulatory Regime13
Recent Regulatory Developments 14
Counterfeit Drugs 15
Intellectual Property 17
Pricing And Reimbursement Regime 18
Kenya Medical Supply Agency (KEMSA)' s Mandate 18
Industry Developments21
Epidemiology 21
Table: Leading Causes Of Death In Kenya, 2002 23
Healthcare Provision 24
Healthcare Sector Financing 25
Healthcare Reforms 26
National Drug Policy 28
Pharmaceutical Sector 28
Recent Pharmaceutical Industries Activities 29
Pharmaceutical Distribution 30
Supply Chain 32
Traditional African Medicine 32
Industry Forecast Scenario 36
Overall Market Forecast 36
Table: Kenya' s Drug Market Expenditure, 2004-2013 37
Key Growth Factors - Industry 38
Table: Kenya' s Health Expenditure, 2004-2013 38
Key Growth Factors - Macroeconomic 39
Table: Kenya - Economic Activity, 2006 - 2013 41
Prescription Drug Market Forecast 42
Prescription Drug Market Forecast 42
Table: Kenya' s Prescription Drug Market, 2004-2013 (KESmn unless otherwise indicated) 43
OTC Drug Market Forecast 44
Table: Kenya' s OTC Market, 2004-2013 45
Patented Drug Market Forecast 46
Table: Kenya' s Patented Drug Market, 2004-2013 46
Generics Market Forecast 47
Table: Kenya' s Generic Drug Market, 2004-2013 47
Pharmaceutical Export/Import Forecasts 48
Table: Kenya' s Pharmaceutical Trade Balance, 2004-2013 (US$mn) 48
Other Healthcare Data Forecasts 49
Table: Kenya' s Other Health Indicators, 2004-2013 49
Key Risks To BMI' s Forecasts 50
Competitive Landscape51
Company Profiles52
Multinationals 52
GlaxoSmithKline 52
Pfizer 54
Novartis 55
Sanofi-Aventis 56
Merck & Co 57
Indigenous Producers 58
Dawa Limited 58
Universal Corporation Limited 59
Shelys Pharmaceuticals 61
Regal Pharmaceuticals 62
High Chem East Africa 62
Country Snapshot: Kenya Demographic Data 63
Section 1: Population 63
Table: Demographic Indicators, 2005-2030 63
Table: Rural/Urban Breakdown, 2005-2030 64
Section 2: Education And Healthcare 64
Table: Education, 2002-2005 64
Table: Vital Statistics, 2005-2030 64
Section 3: Labour Market And Spending Power 65
Table: Consumer Expenditure, 2000-2012 (US$) 65
BMI Forecast Modelling66
How We Generate Our Pharmaceutical Industry Forecasts 66
Pharmaceutical Business Environment Ratings Methodology 67
Ratings Overview 67
Table: Pharmaceutical Business Environment Indicators 68
Weighting 69
Table: Weighting Of Components 69
Sources 69